CA2765463C - Methods for treating or preventing fatigue - Google Patents
Methods for treating or preventing fatigue Download PDFInfo
- Publication number
- CA2765463C CA2765463C CA2765463A CA2765463A CA2765463C CA 2765463 C CA2765463 C CA 2765463C CA 2765463 A CA2765463 A CA 2765463A CA 2765463 A CA2765463 A CA 2765463A CA 2765463 C CA2765463 C CA 2765463C
- Authority
- CA
- Canada
- Prior art keywords
- compound
- sleep
- fatigue
- test compound
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21908209P | 2009-06-22 | 2009-06-22 | |
US61/219,082 | 2009-06-22 | ||
PCT/US2010/039313 WO2011005473A2 (en) | 2009-06-22 | 2010-06-21 | Methods for treating or preventing fatigue |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2765463A1 CA2765463A1 (en) | 2011-01-13 |
CA2765463C true CA2765463C (en) | 2018-10-09 |
Family
ID=43429751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2765463A Expired - Fee Related CA2765463C (en) | 2009-06-22 | 2010-06-21 | Methods for treating or preventing fatigue |
Country Status (13)
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0613697A2 (pt) | 2005-06-08 | 2011-01-25 | Sk Holdings Co Ltd | tratamento de distúrbios de sono-vigìlia |
CN106727486A (zh) * | 2009-06-22 | 2017-05-31 | 爱思开生物制药株式会社 | 治疗或预防疲劳的方法 |
CN102762201B (zh) | 2009-11-06 | 2013-12-18 | 爱思开生物制药株式会社 | 注意力缺陷/多动症的治疗方法 |
MX350745B (es) * | 2009-11-06 | 2017-09-14 | Sk Biopharmaceuticals Co Ltd * | El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia. |
US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
ES2554459T3 (es) | 2011-12-21 | 2015-12-21 | Innobioscience, Llc | Terapia combinada con interferón beta y andrografólidos para la esclerosis múltiple |
DK2968208T3 (da) | 2013-03-13 | 2022-08-22 | Jazz Pharmaceuticals Ireland Ltd | Behandling af kataplexi |
KR20160030955A (ko) * | 2013-07-12 | 2016-03-21 | 에스케이바이오팜 주식회사 | 금연의 촉진 |
KR102309836B1 (ko) | 2013-07-18 | 2021-10-12 | 에스케이바이오팜 주식회사 | 비만의 치료 |
JP6742904B2 (ja) * | 2013-11-08 | 2020-08-19 | レガシー ヘルスケア リミテッド | ガンおよびガン共存症の治療に使用するための組成物 |
TWI698415B (zh) | 2014-02-28 | 2020-07-11 | 南韓商愛思開生物製藥股份有限公司 | 胺基羰基胺基甲酸酯化合物 |
US10888542B2 (en) | 2014-02-28 | 2021-01-12 | Sk Biopharmaceuticals Co., Ltd. | Aminocarbonylcarbamate compounds |
JP7219213B2 (ja) | 2016-09-06 | 2023-02-07 | ジャズ ファーマスティカルズ アイルランド リミテッド | (r)-2-アミノ-3-フェニルプロピルカルバメートの溶媒和物フォーム |
US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
US10710958B2 (en) * | 2016-10-06 | 2020-07-14 | Jazz Pharmaceuticals Ireland Limited | Carbamoyl phenylalaninol compounds and uses thereof |
CA3065522A1 (en) | 2017-06-02 | 2018-12-06 | Jazz Pharmaceuticals Ireland Limited | Methods and compositions for treating excessive sleepiness |
CA3071779A1 (en) | 2017-07-31 | 2019-02-07 | Jazz Pharmaceuticals Ireland Limited | Carbamoyl phenylalaninol analogs and uses thereof |
JP7428480B2 (ja) * | 2019-06-06 | 2024-02-06 | 雪印メグミルク株式会社 | 睡眠改善用組成物及び組成物を含む食品、医薬品、飼料 |
US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
KR102390194B1 (ko) | 2020-08-03 | 2022-04-25 | 셀라이온바이오메드 주식회사 | 페닐알킬 카바메이트 화합물을 포함하는 Kca3.1채널 매개질환 치료용 조성물 |
AU2022390879A1 (en) * | 2021-11-16 | 2024-06-13 | Axsome Malta Ltd. | Methods and compositions for treating cognitive impairment |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ260667A (en) | 1993-06-10 | 1997-05-26 | Lilly Co Eli | Preventing emesis or treating sexual dysfunction using tetrahydrobenz[cd]indole 6-carboxamides |
KR100197892B1 (ko) * | 1994-09-09 | 1999-06-15 | 남창우 | 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 |
US5756817C1 (en) | 1995-02-11 | 2001-04-17 | Sk Corp | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same |
KR0173862B1 (ko) | 1995-02-11 | 1999-04-01 | 조규향 | O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
KR0173863B1 (ko) | 1995-04-10 | 1999-04-01 | 조규향 | 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
WO1998015626A2 (en) | 1996-10-08 | 1998-04-16 | Institute Of Child Health | Mutant ciita molecule and uses thereof |
EP0873308B1 (en) * | 1996-10-10 | 2002-01-02 | SK Corporation | O-carbamoyl-phenylalaninol compounds and their pharmaceutically useful salts |
AU4674797A (en) | 1996-10-22 | 1998-05-15 | Ortho Pharmaceutical Corporation | Phenylalaninol derivatives for the treatment of central nervous system disorders |
US20040229951A1 (en) | 2003-05-15 | 2004-11-18 | Arthur Vanmoor | Method of treating fatigue by enhancing the effectiveness of the human immune system |
RU2267319C2 (ru) * | 2003-07-15 | 2006-01-10 | Общество с ограниченной ответственностью "Интер-Кэр" | Фармацевтическая композиция и способ лечения синдрома хронической усталости с ее использованием |
US20050080268A1 (en) | 2003-10-08 | 2005-04-14 | Yong-Moon Choi | Process of preparing O-carbamoyl compounds in the presence of active amine group |
MX2007005172A (es) | 2004-10-28 | 2007-06-22 | Sk Corp | Terapia adjunta para la depresion. |
BRPI0613697A2 (pt) * | 2005-06-08 | 2011-01-25 | Sk Holdings Co Ltd | tratamento de distúrbios de sono-vigìlia |
CA2612672C (en) | 2005-06-22 | 2014-10-14 | Janssen Pharmaceutica, N.V. | Treatment for sexual dysfunction |
KR101199499B1 (ko) | 2005-07-26 | 2012-11-09 | 얀센 파마슈티카 엔.브이. | 물질 관련 장애를 치료하는 방법 |
MX2009003926A (es) | 2006-10-13 | 2009-06-26 | Janssen Pharmaceutica Nv | Composiciones de fenilalquilamino-carbamato. |
CN106727486A (zh) | 2009-06-22 | 2017-05-31 | 爱思开生物制药株式会社 | 治疗或预防疲劳的方法 |
US8232315B2 (en) | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
CN102762201B (zh) | 2009-11-06 | 2013-12-18 | 爱思开生物制药株式会社 | 注意力缺陷/多动症的治疗方法 |
MX350745B (es) | 2009-11-06 | 2017-09-14 | Sk Biopharmaceuticals Co Ltd * | El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia. |
US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
DK2968208T3 (da) * | 2013-03-13 | 2022-08-22 | Jazz Pharmaceuticals Ireland Ltd | Behandling af kataplexi |
JP6215740B2 (ja) * | 2014-03-14 | 2017-10-18 | 本田技研工業株式会社 | 部品の締結構造 |
-
2010
- 2010-06-21 CN CN201710080968.3A patent/CN106727486A/zh active Pending
- 2010-06-21 EP EP10797541.9A patent/EP2445490B1/en active Active
- 2010-06-21 KR KR1020197026173A patent/KR102173587B1/ko active IP Right Grant
- 2010-06-21 IN IN624DEN2012 patent/IN2012DN00624A/en unknown
- 2010-06-21 AU AU2010270971A patent/AU2010270971B2/en active Active
- 2010-06-21 KR KR1020127001795A patent/KR20120098578A/ko active Application Filing
- 2010-06-21 KR KR1020177020249A patent/KR102021075B1/ko active IP Right Grant
- 2010-06-21 CA CA2765463A patent/CA2765463C/en not_active Expired - Fee Related
- 2010-06-21 MX MX2012000034A patent/MX2012000034A/es active IP Right Grant
- 2010-06-21 BR BRPI1015233A patent/BRPI1015233A2/pt not_active Application Discontinuation
- 2010-06-21 US US13/379,793 patent/US8741950B2/en active Active
- 2010-06-21 CN CN2010800277527A patent/CN102481274A/zh active Pending
- 2010-06-21 RU RU2012101947/15A patent/RU2567801C2/ru active
- 2010-06-21 WO PCT/US2010/039313 patent/WO2011005473A2/en active Application Filing
- 2010-06-21 JP JP2012517622A patent/JP6095366B2/ja active Active
- 2010-06-22 TW TW099120382A patent/TWI453014B/zh active
-
2014
- 2014-05-07 US US14/271,503 patent/US9464041B2/en active Active
-
2015
- 2015-07-03 JP JP2015134556A patent/JP6368285B2/ja active Active
-
2016
- 2016-09-16 US US15/268,060 patent/US9999609B2/en active Active
-
2018
- 2018-05-18 US US15/983,944 patent/US10507192B2/en active Active
- 2018-07-05 JP JP2018128318A patent/JP2018188450A/ja active Pending
-
2019
- 2019-10-31 US US16/670,382 patent/US20200061017A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10507192B2 (en) | Methods for treating or preventing fatigue using O-carbamoyl-phenylalaninol compounds | |
KR20070099031A (ko) | 4-아미노-2-(3-메틸-2,6-디옥소피페리딘-3-일)-이소인돌-1,3-디온을 사용한 방법 및 조성물 | |
EP2965756B1 (en) | Selective ep4 receptor antagonistic substance for treatment of cancer | |
US20160279160A1 (en) | Compositions comprising spicamycin derivatives and methods of use thereof | |
EP2349285B1 (en) | Nanoemulsions comprising Spicamycin derivatives for use in the treatment of pain | |
US20220125844A1 (en) | Opioid antagonists for use in patients using chimeric antigen receptor t and natural killer (nk) cell therapy | |
US10646479B2 (en) | Use of N-(4-iodobenzoylamino)-5-ethyl-1,2,3,6-tetrahydropyridine as a treatment for cancer | |
WO2015061481A1 (en) | Methods of treating liquid tumors using compositions comprising spicamycin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20150413 |
|
MKLA | Lapsed |
Effective date: 20210621 |